Product
Nandrolone Decanoate
Name
Nandrolone Decanoate
INN Name
Nandrolone Decanoate
FDA Approved
Yes
4 clinical trials
1 organization
10 indications
1 document
Indication
SarcopeniaIndication
Aplastic AnemiaIndication
Bone Marrow Failure SyndromesIndication
Idiopathic Pulmonary FibrosisIndication
Telomere ShorteningIndication
ArrestIndication
BoneIndication
DevelopmentIndication
GrowthIndication
Femoroacetabular ImpingementClinical trial
Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Nandrolone Decanoate Therapy and Therapy With Complex Physiotherapy and Diet in the Treatment of SarcopeniaStatus: Recruiting, Estimated PCD: 2026-06-12
Clinical trial
Male Hormones for Telomere Related DiseasesStatus: Completed, Estimated PCD: 2017-02-01
Clinical trial
Role of Anabolic Steroid and Propranolol in Paediatric Burn- A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2023-09-28
Clinical trial
Peri-Operative Testosterone Administration in Primary Hip ArthroscopyStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Organization
Watson Laboratories, Inc.